Steiger U et al., 1990: Prospective study of twelve hydatid patients on albendazole showing that transaminases rose in ten of twelve and that three had major side effects including hepatotoxicity and neutropenia. It also shows albendazole induces its own metabolism.
Transaminase levels increased in 10 of the 12 patients during long-term albendazole treatment, and major side effects, including hepatotoxicity, neutropenia, and alopecia, were observed in three patients.
Steiger U et al., 1990: Prospective study of twelve hydatid patients on albendazole showing that transaminases rose in ten of twelve and that three had major side effects including hepatotoxicity and neutropenia. It also shows albendazole induces its own metabolism. Prospective observational study; N=12; Switzerland (University of Berne); albendazole at standard long-term hydatid dosing, 4-week cycles, exact mg/kg not stated in the abstract. Funder: not stated; Swiss national research support. Declared conflicts: none recorded. Comparator: each patient untreated (aminopyrine breath test without treatment). Relevant to C3 as the class precedent for both hepatotoxicity and marrow suppression at sustained high exposure.
